Bothra Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.61 M
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.76 Cr
- Revenue Growth %
- Profit Growth 42.35%
- Ebitda 98.61%
- Net Worth -10.88%
- Total Assets -2.49%
About Bothra Biotech
Bothra Biotech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 1995 and has a history of 29 years and ten months. Its registered office is in Jaipur, Rajasthan, India.
The Corporate was formerly known as Raspberry Renaissance Pvt Ltd. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.61 M.
The company currently has active open charges totaling ₹1.76 Cr.
Rajendra Mehta and Urmila Bothra serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01100RJ1995PTC009749
- Company No.
009749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 1995
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Bothra Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Mehta  | Director | 17-Sep-2020 | Current |
| Urmila Bothra | Director | 24-Mar-1995 | Current |
Financial Performance of Bothra Biotech.
Bothra Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 42.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bothra Biotech?
In 2021, Bothra Biotech had a promoter holding of 89.04% and a public holding of 10.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.61 M
₹0
Charges Breakdown by Lending Institutions
- Tata Capital Financial Services Limited : 1.17 Cr
- S.B.B.J. : 0.39 Cr
- State Bank Of Bikaner And Jaipur : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2016 | Tata Capital Financial Services Limited | ₹1.17 Cr | Open |
| 18 May 1998 | S.B.B.J. | ₹3.85 M | Open |
| 18 May 1998 | State Bank Of Bikaner And Jaipur | ₹2.10 M | Open |
How Many Employees Work at Bothra Biotech?
Unlock and access historical data on people associated with Bothra Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bothra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bothra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
